Swine flu is replacing COVID on pharmaceutical companies’ target list
Now that the frenetic activity surrounding the corona virus has cooled, a number of major pharmaceutical companies are turning their attention to dealing with the swine flu, specifically dealing with its effects on pigs. Surprised? Well, here are five compelling financial reasons:...